Skip to main navigation Skip to search Skip to main content

Focused multivector ultraviolet (FMUV) technology rapidly eradicates SARS-CoV-2 in-vitro: Implications for hospital disinfection of COVID-19 environments

  • Center for Discovery and Innovation
  • Cornell University

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Focused Multivector Ultraviolet technology rapidly killed the SARS-CoV-2 coronavirus in-vitro. Plates were inoculated with a mean of greater than 106 plaque forming units of USA-WA1 Washington index patient strain of SARS-CoV-2 and exposed to ultraviolet, resulting in mean reductions of 99.99% within 30 seconds, 99.999% within 60 seconds, and 99.9999% within 90 seconds. These results support the effectiveness of Focused Multivector Ultraviolet technology for SARS-CoV-2 disinfection.

Original languageEnglish
Pages (from-to)828-830
Number of pages3
JournalAmerican Journal of Infection Control
Volume50
Issue number7
DOIs
StatePublished - Jul 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Shadowless delivery
  • UV disinfection

Fingerprint

Dive into the research topics of 'Focused multivector ultraviolet (FMUV) technology rapidly eradicates SARS-CoV-2 in-vitro: Implications for hospital disinfection of COVID-19 environments'. Together they form a unique fingerprint.

Cite this